Skip to Content
You are currently on the new version of our website. Access the old version .

54 Results Found

  • Article
  • Open Access
52 Citations
5,025 Views
21 Pages

The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment

  • Gniewomir Latacz,
  • Annamaria Lubelska,
  • Magdalena Jastrzębska-Więsek,
  • Anna Partyka and ,
  • Małgorzata Anna Marć,
  • Grzegorz Satała,
  • Daria Wilczyńska,
  • Magdalena Kotańska,
  • Małgorzata Więcek and
  • Jadwiga Handzlik
  • + 8 authors+ 3 authors

Among serotonin receptors, the 5-HT6 subtype is the most controversial and the least known in the field of molecular mechanisms. The 5-HT6R ligands can be pivotal for innovative treatment of cognitive impairment, but none has reached pharmacological...

(This article belongs to the Special Issue Serotonin in Health and Disease)
  • Article
  • Open Access
2,987 Views
12 Pages

Pro-Cognitive Effect of Royal Jelly Is Linked with Increased Burst Activity of Mesocorticolimbic Dopaminergic Neurons

  • Katarína Bíliková,
  • Daniela Jezova,
  • Daniil Grinchii,
  • Henrieta Oravcová and ,
  • Tatiana Krištof Kraková,
  • Ruslan Paliokha,
  • Hande Özbaşak,
  • Matej Račický and
  • Eliyahu Dremencov
  • + 4 authors+ 0 author

17 November 2025

Background: Royal jelly is a protein-rich honeybee secretion that is used in the nutrition of larvae and adult queens. Previous studies have reported that royal jelly had induced pro-cognitive, anxiolytic, and antidepressant-like effects in laborator...

(This article belongs to the Section Nutrition and Neuro Sciences)
  • Article
  • Open Access
25 Citations
4,207 Views
14 Pages

Mechanisms of the Procognitive Effects of Xanthotoxin and Umbelliferone on LPS-Induced Amnesia in Mice

  • Łukasz Kurach,
  • Sylwia Kulczycka-Mamona,
  • Joanna Kowalczyk,
  • Krystyna Skalicka-Woźniak and ,
  • Anna Boguszewska-Czubara,
  • Nesrine El Sayed,
  • Mitat Osmani,
  • Karol Iwaniak and
  • Barbara Budzyńska
  • + 4 authors+ 0 author

10 February 2021

Neuroinflammation plays an essential role in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease. Although coumarins have been shown to improve cognitive function in animal models and exert anti-inflammatory effects in cell cul...

(This article belongs to the Section Molecular Pharmacology)
  • Article
  • Open Access
16 Citations
5,153 Views
38 Pages

The Phenoxyalkyltriazine Antagonists for 5-HT6 Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases

  • Sylwia Sudoł,
  • Agnieszka Cios,
  • Magdalena Jastrzębska-Więsek,
  • Ewelina Honkisz-Orzechowska and ,
  • Barbara Mordyl,
  • Natalia Wilczyńska-Zawal,
  • Grzegorz Satała,
  • Katarzyna Kucwaj-Brysz,
  • Anna Partyka and
  • Jadwiga Handzlik
  • + 8 authors+ 3 authors

5 October 2021

Among the serotonin receptors, one of the most recently discovered 5-HT6 subtype is an important protein target and its ligands may play a key role in the innovative treatment of cognitive disorders. However, none of its selective ligands have reache...

(This article belongs to the Special Issue Alzheimer’s Disease and Other Dementias-Novel Therapeutic Approaches-2nd Edition)
  • Article
  • Open Access
26 Citations
4,853 Views
24 Pages

Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro

  • Annamaria Lubelska,
  • Gniewomir Latacz,
  • Magdalena Jastrzębska-Więsek,
  • Magdalena Kotańska and ,
  • Rafał Kurczab,
  • Anna Partyka,
  • Małgorzata Anna Marć,
  • Daria Wilczyńska,
  • Agata Doroz-Płonka and
  • Jadwiga Handzlik
  • + 8 authors+ 3 authors

6 December 2019

Though the 5-HT6 serotonin receptor is an important target giving both agonists and antagonists similar therapeutic potency in the treatment of topic CNS-diseases, no 5-HT6R ligand has reached the pharmaceutical market yet due to the too narrow chemi...

(This article belongs to the Section Medicinal Chemistry)
  • Discussion
  • Open Access
44 Citations
26,409 Views
8 Pages

Citicoline: A Superior Form of Choline?

  • Kamil Synoradzki and
  • Paweł Grieb

12 July 2019

Medicines containing citicoline (cytidine-diphosphocholine) as an active principle have been marketed since the 1970s as nootropic and psychostimulant drugs available on prescription. Recently, the inner salt variant of this substance was pronounced...

  • Article
  • Open Access
16 Citations
8,901 Views
15 Pages

Low-Impact Ampakine CX1739 Exerts Pro-Cognitive Effects and Reverses Opiate-Induced Respiratory Depression in Rodents

  • Daniel Pierce Radin,
  • Sheng Zhong,
  • Rok Cerne,
  • Mohammed Shoaib and ,
  • Jeffrey M. Witkin and
  • Arnold Lippa
  • + 1 author+ 0 author

AMPA-glutamate receptors (AMPARs) are expressed throughout the CNS and mediate the majority of fast excitatory synaptic transmission. Ampakines are orally available small molecules that bind allosterically to AMPARs and enhance excitatory currents el...

  • Article
  • Open Access
22 Citations
6,648 Views
13 Pages

2 February 2020

Dehydration risk increases with frailty and functional dependency, but a limited number of studies have evaluated this association in hospitalized geriatric patients. This cross-sectional study aimed to assess the prevalence and determinants of dehyd...

(This article belongs to the Special Issue Body Water Regulation and Nutrient Intake)
  • Article
  • Open Access
29 Citations
5,193 Views
19 Pages

Short- and Long-Term Social Recognition Memory Are Differentially Modulated by Neuronal Histamine

  • Barbara Rani,
  • Bruna Silva-Marques,
  • Rob Leurs,
  • Maria Beatrice Passani and ,
  • Patrizio Blandina and
  • Gustavo Provensi
  • + 1 author+ 0 author

9 April 2021

The ability of recognizing familiar conspecifics is essential for many forms of social interaction including reproduction, establishment of dominance hierarchies, and pair bond formation in monogamous species. Many hormones and neurotransmitters have...

(This article belongs to the Special Issue New Developments in Histamine Research)
  • Article
  • Open Access
6 Citations
2,455 Views
20 Pages

The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO• Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice

  • Agata Płoska,
  • Anna Siekierzycka,
  • Paulina Cieślik,
  • Lawrence W. Dobrucki and ,
  • Leszek Kalinowski and
  • Joanna M. Wierońska
  • + 1 author+ 0 author

29 January 2024

The role of endothelial nitric oxide synthase (eNOS) in the regulation of a variety of biological processes is well established, and its dysfunction contributes to brain pathologies, including schizophrenia or Alzheimer’s disease (AD). Positive...

(This article belongs to the Special Issue The Gaseous Neurotransmitter Nitric Oxide: A Potential Therapeutic Target for Neuropsychiatric and Neurodegenerative Disorders)
  • Article
  • Open Access
11 Citations
2,785 Views
24 Pages

Procognitive, Anxiolytic, and Antidepressant-like Properties of Hyperoside and Protocatechuic Acid Corresponding with the Increase in Serum Serotonin Level after Prolonged Treatment in Mice

  • Jolanta Orzelska-Górka,
  • Katarzyna Dos Santos Szewczyk,
  • Monika Gawrońska-Grzywacz,
  • Mariola Herbet and ,
  • Anna Lesniak,
  • Anna Bielenica,
  • Magdalena Bujalska-Zadrożny and
  • Grażyna Biała
  • + 3 authors+ 0 author

5 December 2023

Two polyphenols–hyperoside (HYP) and protocatechuic acid (PCA) were reported to exert antidepressant activity in rodents after acute treatment. Our previous study also showed that this activity might have been influenced by the monoaminergic sy...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
5 Citations
3,778 Views
21 Pages

Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice

  • Elżbieta Żmudzka,
  • Klaudia Lustyk,
  • Monika Głuch-Lutwin,
  • Małgorzata Wolak and ,
  • Jolanta Jaśkowska,
  • Marcin Kołaczkowski,
  • Jacek Sapa and
  • Karolina Pytka
  • + 3 authors+ 0 author

24 January 2023

Depression, anxiety, and schizophrenia may coexist in psychiatric patients. Moreover, these disorders are very often associated with cognitive impairments. However, pharmacotherapy of these conditions remains challenging due to limited drug effective...

(This article belongs to the Special Issue Recent Advances in the Pharmacology of Serotonin and Its Receptors)
  • Review
  • Open Access
64 Citations
12,944 Views
32 Pages

CaMKII and CaMKIV are calcium/calmodulin-dependent kinases playing a rudimentary role in many regulatory processes in the organism. These kinases attract increasing interest due to their involvement primarily in memory and plasticity and various cell...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
20 Citations
5,067 Views
15 Pages

Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease

  • Damiana Leo,
  • Giorgia Targa,
  • Stefano Espinoza,
  • Agnès Villers and ,
  • Raul R. Gainetdinov and
  • Laurence Ris
  • + 1 author+ 0 author

Worldwide, approximately 27 million people are affected by Alzheimer’s disease (AD). AD pathophysiology is believed to be caused by the deposition of the β-amyloid peptide (Aβ). Aβ can reduce long-term potentiation (LTP), a form...

(This article belongs to the Special Issue Trace Amine-Associated Receptors in Neuropsychiatric Disorders)
  • Article
  • Open Access
5 Citations
2,324 Views
27 Pages

26 September 2024

Cerebral dopamine neurotrophic factor (CDNF) is an unconventional neurotrophic factor because it does not bind to a known specific receptor on the plasma membrane and functions primarily as an unfolded protein response (UPR) regulator in the endoplas...

(This article belongs to the Special Issue Role of Serotonin in Brain Function)
  • Article
  • Open Access
17 Citations
2,848 Views
12 Pages

Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies

  • Yongjian Chen,
  • Kang Ma,
  • Peilong Xu,
  • Hongzong Si and ,
  • Yunbo Duan and
  • Honglin Zhai
  • + 1 author+ 0 author

26 October 2022

The purpose of the present study aims to develop a satisfactory model for predicting pro-social and pro-cognitive effects on azinesulfonamides of cyclic amine derivatives as potential antipsychotics. The three dimensional-quantitative structure affin...

  • Review
  • Open Access
11 Citations
10,785 Views
27 Pages

Third-Generation Antipsychotics: The Quest for the Key to Neurotrophism

  • Federico Mucci,
  • Alessandro Arone,
  • Riccardo Gurrieri,
  • Francesco Weiss and ,
  • Gerardo Russomanno and
  • Donatella Marazziti
  • + 1 author+ 0 author

1 March 2025

Antipsychotic drugs (APs) have profoundly changed the treatment landscape for psychiatric disorders, yet their impact on neuroplasticity and neurotrophism remains only partially understood. While second-generation antipsychotics (SGAs) are associated...

(This article belongs to the Section Pharmaceutical Science)
  • Article
  • Open Access
166 Views
26 Pages

Deferasirox, an Oral Iron Chelator, Confers Antidepressant and Procognitive Effects in a Rat Model of Depression: Hippocampal Ferroptosis, Synaptopathy, and Neurodegeneration

  • Sawsan Aboul-Fotouh,
  • Mohamed Z. Habib,
  • Esraa M. Elnahas,
  • Yasmin M. Aboul-Ela and ,
  • Ghada A. Abdel-Latif,
  • Samah S. Abbas,
  • Ismail Mohamed Elshaffei,
  • Hekmat M. El Magdoub,
  • Doaa R. Sadek and
  • Lobna H. Khedr
  • + 10 authors+ 5 authors

2 November 2026

Background: Disrupted iron homeostasis is increasingly perceived as a key driver of major depressive disorder pathogenesis; hence, targeting ferroptotic cascades may reveal novel therapeutic targets. This study evaluated the neuroprotective potential...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
17 Citations
5,517 Views
16 Pages

17 November 2018

Evidence to date suggests that opioids such as methadone may be associated with cognitive impairment. Growth hormone (GH) and insulin-like growth factor-1 (IGF-1) are suggested to be neuroprotective and procognitive in the brain and may therefore cou...

(This article belongs to the Special Issue Growth Hormone (GH): Multiple Therapeutic Possibilities and Molecular Mechanisms of Action)
  • Article
  • Open Access
5 Citations
3,672 Views
18 Pages

N-Skatyltryptamines—Dual 5-HT6R/D2R Ligands with Antipsychotic and Procognitive Potential

  • Agata Hogendorf,
  • Adam S. Hogendorf,
  • Rafał Kurczab,
  • Grzegorz Satała and ,
  • Bernadeta Szewczyk,
  • Paulina Cieślik,
  • Gniewomir Latacz,
  • Jadwiga Handzlik,
  • Tomasz Lenda and
  • Andrzej J. Bojarski
  • + 9 authors+ 4 authors

29 July 2021

A series of N-skatyltryptamines was synthesized and their affinities for serotonin and dopamine receptors were determined. Compounds exhibited activity toward 5-HT1A, 5-HT2A, 5-HT6, and D2 receptors. Substitution patterns resulting in affinity/activi...

(This article belongs to the Special Issue Recent Developments in Serotonin Receptors Research)
  • Article
  • Open Access
13 Citations
3,521 Views
13 Pages

Biochemical and Behavioral Characterization of IN14, a New Inhibitor of HDACs with Antidepressant-Like Properties

  • Heidy Martínez-Pacheco,
  • Ofir Picazo,
  • Adolfo López-Torres,
  • Jean-Pascal Morin and ,
  • Karla Viridiana Castro-Cerritos,
  • Rossana Citlali Zepeda and
  • Gabriel Roldán-Roldán
  • + 2 authors+ 0 author

14 February 2020

Evidence suggests that histone deacetylases (HDACs) inhibitors could be used as an effective treatment for some psychiatric and neurological conditions such as depression, anxiety and age-related cognitive decline. However, non-specific HDAC inhibiti...

  • Article
  • Open Access
19 Citations
3,357 Views
15 Pages

Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice

  • Manuela Dicarlo,
  • Patrizia Pignataro,
  • Roberta Zerlotin,
  • Clelia Suriano and ,
  • Chiara Zecca,
  • Maria Teresa Dell’Abate,
  • Giuseppina Storlino,
  • Angela Oranger,
  • Lorenzo Sanesi and
  • Silvia Colucci
  • + 8 authors+ 3 authors

As a result of physical exercise, muscle releases multiple exerkines, such as “irisin”, which is thought to induce pro-cognitive and antidepressant effects. We recently demonstrated in young healthy mice the mitigation of depressive behav...

(This article belongs to the Special Issue Molecular Pharmacology of Antidepressants)
  • Article
  • Open Access
25 Citations
8,473 Views
14 Pages

Effects of Repetitive Transcranial Magnetic Stimulation over Prefrontal Cortex on Attention in Psychiatric Disorders: A Systematic Review

  • Larissa Hauer,
  • Johann Sellner,
  • Francesco Brigo,
  • Eugen Trinka and ,
  • Luca Sebastianelli,
  • Leopold Saltuari,
  • Viviana Versace,
  • Yvonne Höller and
  • Raffaele Nardone
  • + 4 authors+ 0 author

27 March 2019

Repetitive transcranial magnetic stimulation (rTMS) may be effective for enhancing cognitive functioning. In this review, we aimed to systematically evaluate the effects of rTMS on attention in psychiatric diseases. In particular, we searched PubMed...

(This article belongs to the Section Mental Health)
  • Article
  • Open Access
11 Citations
6,359 Views
22 Pages

10 November 2022

This determination of the mitochondrial effect of pharmacologically different antidepressants (agomelatine, ketamine and vortioxetine) was evaluated and quantified in vitro in pig brain-isolated mitochondria. We measured the activity of mitochondrial...

(This article belongs to the Special Issue Pathogenesis and Treatment Mechanisms of Depression)
  • Article
  • Open Access
14 Citations
9,866 Views
25 Pages

Mitochondrial dysfunction is involved in the pathophysiology of psychiatric and neurodegenerative disorders and can be used as a modulator and/or predictor of treatment responsiveness. Understanding the mitochondrial effects of antidepressants is imp...

(This article belongs to the Special Issue Oxidative Metabolism and Mitochondrial Dysfunction in Metabolic Diseases)
  • Review
  • Open Access
12 Citations
2,714 Views
12 Pages

Accumulation of hyper-phosphorylated tau and amyloid beta (Aβ) are key pathological hallmarks of Alzheimer’s disease (AD). Increasing evidence indicates that in the early pre-clinical stages of AD, phosphorylation and build-up of tau drive...

(This article belongs to the Section Molecular Neurobiology)
  • Review
  • Open Access
9 Citations
5,699 Views
12 Pages

Impact of 5-HT6 Receptor Subcellular Localization on Its Signaling and Its Pathophysiological Roles

  • Séverine Chaumont-Dubel,
  • Sonya Galant,
  • Matthieu Prieur,
  • Tristan Bouschet and ,
  • Joël Bockaert and
  • Philippe Marin
  • + 1 author+ 0 author

27 January 2023

The serotonin (5-HT)6 receptor still raises particular interest given its unique spatio-temporal pattern of expression among the serotonin receptor subtypes. It is the only serotonin receptor specifically expressed in the central nervous system, wher...

(This article belongs to the Section Cell Signaling)
  • Article
  • Open Access
14 Citations
4,605 Views
8 Pages

5 May 2021

Phytochemicals, such as monoterpenes, polyphenols, curcuminoids, and flavonoids, are known to have anti-inflammatory, antioxidant, neuroprotective, and procognitive effects. In this study, the effects of several polyhydroxy flavonoids, as derivatives...

(This article belongs to the Section Cell Signaling)
  • Review
  • Open Access
7 Citations
4,732 Views
24 Pages

Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?

  • Kinga Czarnota-Łydka,
  • Katarzyna Kucwaj-Brysz,
  • Patryk Pyka,
  • Wawrzyniec Haberek and ,
  • Sabina Podlewska and
  • Jadwiga Handzlik
  • + 1 author+ 0 author

In view of the unsatisfactory treatment of cognitive disorders, in particular Alzheimer’s disease (AD), the aim of this review was to perform a computer-aided analysis of the state of the art that will help in the search for innovative polyphar...

(This article belongs to the Section Molecular Pharmacology)
  • Article
  • Open Access
6 Citations
4,399 Views
21 Pages

Glycyrrhizinic Acid and Phosphatidylcholine Combination as a Preventive Therapy for Experimental Murine Non-Alcoholic Steatohepatitis

  • Veronika A. Prikhodko,
  • Tatyana M. Matuzok,
  • Vadim E. Karev,
  • Anna V. Karavaeva and ,
  • Olga M. Spasenkova,
  • Nadezhda V. Kirillova,
  • Dmitry Yu. Ivkin and
  • Sergey V. Okovityi
  • + 3 authors+ 0 author

29 January 2024

Non-alcoholic metabolic-associated steatohepatitis (MASH) is a condition characterized by increasingly high prevalence and incidence, and also represents an important unmet medical need when it comes to effective pharmacotherapy. In this work, we aim...

  • Article
  • Open Access
14 Citations
3,900 Views
18 Pages

Neuroprotective Effect of Yucca schidigera Roezl ex Ortgies Bark Phenolic Fractions, Yuccaol B and Gloriosaol A on Scopolamine-Induced Memory Deficits in Zebrafish

  • Łukasz Pecio,
  • Solomiia Kozachok,
  • Ion Brinza,
  • Razvan Stefan Boiangiu and ,
  • Lucian Hritcu,
  • Cornelia Mircea,
  • Ana Flavia Burlec,
  • Oana Cioanca,
  • Monica Hancianu and
  • Wiesław Oleszek
  • + 7 authors+ 2 authors

Y. schidigera contains a number of unusual polyphenols, derivatives of resveratrol and naringenin, called spiro-flavostilbenoids, which have potent in vitro anti-inflammatory, antioxidant, and moderate cholinesterase inhibitory activities. To date, t...

(This article belongs to the Special Issue Novel Compounds in the Treatment of the CNS Disorders)
  • Article
  • Open Access
2,299 Views
19 Pages

We investigated the cellular and neurophysiological mechanisms underlying the pro-cognitive effects of 5-HT4R activation in hippocampal–prefrontal pathways. Our findings show that, in addition to pyramidal neurons, 30–60% of parvalbumin+...

(This article belongs to the Special Issue Biological Research of Rhythms in the Nervous System)
  • Article
  • Open Access
3 Citations
2,132 Views
20 Pages

Repurposing Caffeine, Metformin, and Furosemide to Target Schizophrenia-Related Impairments in a Triple-Hit Rat Model

  • Gyongyi Horvath,
  • Szonja Bianka Plesz,
  • Eszter Ducza,
  • Dorottya Varga and ,
  • Edina Szucs,
  • Sándor Benyhe,
  • Leatitia Gabriella Adlan,
  • Gabor Braunitzer and
  • Gabriella Kekesi
  • + 4 authors+ 0 author

The limited efficacy of antipsychotics in treating the negative and cognitive symptoms of schizophrenia has prompted the exploration of adjuvant therapies. Several drugs developed for other indications—including caffeine, metformin, and furosem...

(This article belongs to the Section Molecular Neurobiology)
  • Review
  • Open Access
91 Citations
15,473 Views
22 Pages

Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies

  • Nina Dedic,
  • Heather Dworak,
  • Courtney Zeni,
  • Grazia Rutigliano and
  • Oliver D. Howes

7 December 2021

Trace amine-associated receptor 1 (TAAR1) has emerged as a promising therapeutic target for neuropsychiatric disorders due to its ability to modulate monoaminergic and glutamatergic neurotransmission. In particular, agonist compounds have generated i...

(This article belongs to the Special Issue Trace Amine-Associated Receptors in Neuropsychiatric Disorders)
  • Article
  • Open Access
7 Citations
4,105 Views
20 Pages

The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases

  • Oliwia Koszła,
  • Przemysław Sołek,
  • Sylwia Woźniak,
  • Ewa Kędzierska and ,
  • Tomasz M. Wróbel,
  • Magda Kondej,
  • Aneta Archała,
  • Piotr Stępnicki,
  • Grażyna Biała and
  • Agnieszka A. Kaczor
  • + 6 authors+ 1 author

23 November 2020

The treatment of memory impairments associated with the central nervous system diseases remains an unmet medical need with social and economic implications. Here we show, that a multi-target ligand of aminergic G protein-coupled receptors with antips...

(This article belongs to the Special Issue Pharmacology of Neurodegenerative Diseases)
  • Article
  • Open Access
9 Citations
6,267 Views
11 Pages

Evaluation of the Effect of Cariprazine on Memory and Cognition in Experimental Rodent Models

  • Hristina Ivanova Zlatanova,
  • Maria Todorova Georgieva-Kotetarova,
  • Natalia Borisova Vilmosh and
  • Ilin Kostadinov Kandilarov

The main symptoms of schizophrenia are categorized as positive, negative, and cognitive. Cognitive impairments do not generally respond to antipsychotics. Cariprazine is a novel antipsychotic conceived with the idea that high affinity for D3 receptor...

(This article belongs to the Special Issue Challenges in Translational Psychiatry)
  • Review
  • Open Access
71 Citations
12,413 Views
10 Pages

2 March 2011

Studies utilizing selective pharmacological antagonists or targeted gene deletion have demonstrated thattype 5 metabotropic glutamate receptors (mGluR5) are critical mediators and potential therapeutic targets for the treatment of numerous disorders...

(This article belongs to the Special Issue Neuroactive Compounds)
  • Article
  • Open Access
22 Citations
6,400 Views
14 Pages

Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System

  • Claudia Sagheddu,
  • Nicholas Pintori,
  • Predrag Kalaba,
  • Vladimir Dragačević and ,
  • Gessica Piras,
  • Jana Lubec,
  • Nicola Simola,
  • Maria Antonietta De Luca,
  • Gert Lubec and
  • Marco Pistis
  • + 5 authors+ 0 author

Treatments for cognitive impairments associated with neuropsychiatric disorders, such as attention deficit hyperactivity disorder or narcolepsy, aim at modulating extracellular dopamine levels in the brain. CE-123 (5-((benzhydrylsulfinyl)methyl) thia...

(This article belongs to the Section Molecular Medicine)
  • Article
  • Open Access
26 Citations
6,989 Views
29 Pages

Cotinine and 6-Hydroxy-L-Nicotine Reverses Memory Deficits and Reduces Oxidative Stress in Aβ25-35-Induced Rat Model of Alzheimer’s Disease

  • Razvan Stefan Boiangiu,
  • Marius Mihasan,
  • Dragos Lucian Gorgan,
  • Bogdan Alexandru Stache and ,
  • Brindusa Alina Petre and
  • Lucian Hritcu
  • + 1 author+ 0 author

18 August 2020

The nicotinic derivatives, cotinine (COT), and 6-hydroxy-L-nicotine (6HLN), showed promising cognitive-improving effects without exhibiting the nicotine’s side-effects. Here, we investigated the impact of COT and 6HLN on memory impairment and t...

(This article belongs to the Special Issue Oxidative Stress and Inflammation in the Nervous System)
  • Article
  • Open Access
2 Citations
3,057 Views
15 Pages

Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice

  • Elżbieta Żmudzka,
  • Klaudia Lustyk,
  • Kinga Sałaciak,
  • Agata Siwek and ,
  • Jolanta Jaśkowska,
  • Marcin Kołaczkowski,
  • Jacek Sapa and
  • Karolina Pytka
  • + 3 authors+ 0 author

Memory impairments constitute a significant problem worldwide, and the COVID-19 pandemic dramatically increased the prevalence of cognitive deficits. Patients with cognitive deficits, specifically memory disturbances, have underlying comorbid conditi...

(This article belongs to the Section Pharmacology)
  • Review
  • Open Access
150 Citations
45,348 Views
33 Pages

Artemisia absinthium L.—Importance in the History of Medicine, the Latest Advances in Phytochemistry and Therapeutical, Cosmetological and Culinary Uses

  • Agnieszka Szopa,
  • Joanna Pajor,
  • Paweł Klin,
  • Agnieszka Rzepiela and ,
  • Hosam O. Elansary,
  • Fahed A. Al-Mana,
  • Mohamed A. Mattar and
  • Halina Ekiert
  • + 3 authors+ 0 author

19 August 2020

Artemisia absinthium—wormwood (Asteraceae)—is a very important species in the history of medicine, formerly described in medieval Europe as “the most important master against all exhaustions”. It is a species known as a medici...

(This article belongs to the Collection Bioactive Compounds in Plants)
  • Review
  • Open Access
7 Citations
3,504 Views
21 Pages

The Lactate Nexus: A Molecular Bridge Linking Physical Activity, Sleep, and Cognitive Enhancement

  • Alimjan Ablitip,
  • Kefeng Zheng,
  • Hao Ding,
  • Yicong Cui and ,
  • Xindong Ma and
  • Yanwei You
  • + 1 author+ 0 author

Physical activity (PA) and quality sleep are essential for cognitive health, providing synergistic protection against age-related cognitive decline. However, the shared molecular pathways that explain their combined and interactive benefits remain po...

(This article belongs to the Section Molecular and Translational Medicine)
  • Review
  • Open Access
33 Citations
7,125 Views
34 Pages

Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease

  • Barbara Miziak,
  • Barbara Błaszczyk and
  • Stanisław J. Czuczwar

Alzheimer’s disease (AD; progressive neurodegenerative disorder) is associated with cognitive and functional impairment with accompanying neuropsychiatric symptoms. The available pharmacological treatment is of a symptomatic nature and, as such, it d...

(This article belongs to the Special Issue Treatment of Alzheimer Disease)
  • Review
  • Open Access
204 Citations
14,236 Views
35 Pages

Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer’s Disease

  • Giuseppe Caruso,
  • Justyna Godos,
  • Anna Privitera,
  • Giuseppe Lanza and ,
  • Sabrina Castellano,
  • Alessio Chillemi,
  • Oliviero Bruni,
  • Raffaele Ferri,
  • Filippo Caraci and
  • Giuseppe Grosso
  • + 5 authors+ 0 author

15 February 2022

Cognitive impairment, also known as cognitive decline, can occur gradually or suddenly and can be temporary or more permanent. It represents an increasingly important public health problem and can depend on normal aging or be linked to different neur...

(This article belongs to the Special Issue Polyphenols and Polyphenol-Rich Foods in Neurodegenerative Disorders)
  • Article
  • Open Access
5 Citations
2,294 Views
21 Pages

Inhibition of IRAP Enhances the Expression of Pro-Cognitive Markers Drebrin and MAP2 in Rat Primary Neuronal Cells

  • Frida Stam,
  • Sara Bjurling,
  • Erik Nylander,
  • Esther Olaniran Håkansson and ,
  • Nicholas Barlow,
  • Johan Gising,
  • Mats Larhed,
  • Luke R. Odell,
  • Alfhild Grönbladh and
  • Mathias Hallberg
  • + 5 authors+ 0 author

8 November 2024

The insulin-regulated aminopeptidase (IRAP; oxytocinase) is part of the M1 aminopeptidase family and is highly expressed in many tissues, including the neocortex and hippocampus of the brain. IRAP is involved in various physiological functions and ha...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
8 Citations
3,510 Views
17 Pages

The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in Mice

  • Sabna Abdalla,
  • Nermin Eissa,
  • Petrilla Jayaprakash,
  • Rami Beiram and ,
  • Kamil J. Kuder,
  • Dorota Łażewska,
  • Katarzyna Kieć-Kononowicz and
  • Bassem Sadek
  • + 3 authors+ 0 author

12 August 2023

The role of histamine H3 receptors (H3Rs) in memory and the prospective of H3R antagonists in pharmacological control of neurodegenerative disorders, e.g., Alzheimer’s disease (AD), is well-accepted. Therefore, the procognitive effects of acute...

(This article belongs to the Special Issue Dopamine, Histamine, Serotonin—Receptors, Ligands and Their Biological Role in Central Nervous System Diseases)
  • Review
  • Open Access
1 Citations
1,655 Views
13 Pages

Alzheimer’s disease (AD) is an age-related neurodegenerative disorder, characterised by the build-up of amyloid beta (Aβ) plaques and neurofibrillary tangles comprising hyper-phosphorylated tau. Increasing evidence indicates that in the ea...

(This article belongs to the Special Issue New Molecular Insights into the Pathogenesis and Drug Development of Neurodegenerative Diseases: 2nd Edition)
  • Article
  • Open Access
5 Citations
1,724 Views
24 Pages

2 October 2025

Background/Objectives: Scopolamine (SCO) is widely employed as a pharmacological model of anxiety and amnesia in both rodents and zebrafish, the latter representing a valuable translational model in neuropsychopharmacology. The present study aimed to...

(This article belongs to the Special Issue Unveiling Nature's Pharmacy: Exploring Drug Discovery Through Medicinal Plants)
  • Article
  • Open Access
7 Citations
4,300 Views
26 Pages

Therapeutic Efficacy of the Inositol D-Pinitol as a Multi-Faceted Disease Modifier in the 5×FAD Humanized Mouse Model of Alzheimer’s Amyloidosis

  • Dina Medina-Vera,
  • Antonio J. López-Gambero,
  • Julia Verheul-Campos,
  • Juan A. Navarro and ,
  • Laura Morelli,
  • Pablo Galeano,
  • Juan Suárez,
  • Carlos Sanjuan,
  • Beatriz Pacheco-Sánchez and
  • Fernando Rodríguez de Fonseca
  • + 8 authors+ 3 authors

4 December 2024

Background/Objectives: Alzheimer’s disease (AD), a leading cause of dementia, lacks effective long-term treatments. Current therapies offer temporary relief or fail to halt its progression and are often inaccessible due to cost. AD involves mul...

(This article belongs to the Section Lipids)
  • Article
  • Open Access
26 Citations
9,870 Views
9 Pages

Clinical Role of Aspirin in Mood Disorders: A Systematic Review

  • Qin Xiang Ng,
  • Krishnapriya Ramamoorthy,
  • Wayren Loke,
  • Matthew Wei Liang Lee and ,
  • Wee Song Yeo,
  • Donovan Yutong Lim and
  • Vivekanandan Sivalingam
  • + 2 authors+ 0 author

29 October 2019

Worldwide, depression and bipolar disorder affect a large and growing number of people. However, current pharmacotherapy options remain limited. Despite adequate treatment, many patients continue to have subsyndromal symptoms, which predict relapse i...

(This article belongs to the Special Issue Etiology, Pharmacological, and Brain Stimulation Interventions for Bipolar Disorders)

of 2